DEF 14C: CISO Global Majority Stockholders Approve Private Placement and Issuance of Securities via Written Consent
Information Statement
CISO Global informs stockholders that a majority, controlling 51.2% of voting power, approved a private placement and issuance of securities via written consent, negating the need for a stockholder meeting.
Summary
- CISO Global, Inc. is providing an information statement to its stockholders regarding actions approved by written consent of a majority of its stockholders.
- The majority stockholders, controlling approximately 51.2% of the voting power, approved a private placement and issuance of securities.
- This action was taken in lieu of a stockholder meeting, as permitted by Delaware law.
- The approved actions include the issuance of common stock and warrants in connection with a private placement, which implicates Nasdaq Listing Rule 5635 requiring stockholder approval.
- The company received $6.5 million in gross proceeds from the private placement, with the potential for an additional $1.625 million.
- The net proceeds will be used to repay outstanding short-term indebtedness and for general corporate purposes.
- The information statement is being mailed to stockholders on or about January 17, 2025, and the actions will become effective 20 calendar days thereafter.
- The company is not soliciting proxies and no stockholder meeting will be held.
Sentiment
Score: 6
Explanation: The document is primarily informational, detailing a procedural action. While the capital raise is positive for the company's financial position, the potential dilution and associated costs temper the overall sentiment.
Positives
- The private placement provides the company with $6.5 million in gross proceeds, with the potential for an additional $1.625 million, to repay debt and fund operations.
- The written consent of the majority stockholders streamlines the approval process and avoids the costs associated with holding a special meeting of stockholders.
Negatives
- The private placement will result in significant dilution of existing stockholders' equity, with the potential issuance of up to 27,121,828 shares of common stock.
- The company is paying a cash fee of 7.0% of the gross proceeds to the placement agents, as well as issuing warrants to purchase up to 224,945 shares of common stock.
Risks
- The company's common stock price could be negatively impacted by the significant dilution resulting from the private placement.
- The company's ability to achieve its business objectives depends on its ability to effectively deploy the proceeds from the private placement.
- The company is subject to the risks associated with its industry and general economic conditions.
Future Outlook
The company intends to use the net proceeds from the private placement to repay outstanding short-term indebtedness and for general corporate purposes, which may include working capital, capital expenditures, research and development expenditures, acquisitions of additional companies or technologies, and investments.
Industry Context
Many small-cap companies use private placements to raise capital when access to public markets is limited or unfavorable. The use of convertible notes and warrants is a common structure in these types of financings.
Comparison to Industry Standards
- The terms of the private placement, including the original issue discount and placement agent fees, appear to be within the range of typical terms for similar transactions involving small-cap companies.
- Comparable companies that have recently completed similar private placements include [Competitor A] and [Competitor B].
- The use of written consent in lieu of a stockholder meeting is a standard practice permitted under Delaware law.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Board Member | Five former members of the Board | Three new members | January 8, 2025 | Conditioned upon the regulatory filing and mailing of the Information Statement and the $4 million balance of gross proceeds being paid to the Company. |
Stakeholder Impact
- Existing stockholders will experience dilution as a result of the issuance of new shares.
- The company's employees and customers may benefit from the company's improved financial position.
- The company's creditors will benefit from the repayment of outstanding debt.
Next Steps
- The actions approved by the majority stockholders will become effective 20 calendar days after the Information Statement is first mailed to stockholders.
- The company will use the net proceeds from the private placement to repay outstanding short-term indebtedness and for general corporate purposes.
Key Dates
| Date | Description |
|---|---|
| September 18, 2024 | Date of the Placement Agency Agreement with RBW Capital Partners, LLC and Dominari Securities, LLC. |
| December 10, 2024 | Signing date of the Securities Purchase Agreement and receipt of $1 million of gross proceeds. |
| December 10, 2024 | As of this date, the Company could not issue in excess of an aggregate of 2,363,191 shares of Common Stock upon conversion of convertible notes and exercise of the Warrants issued pursuant to the Private Placement, unless the issuance of such excess shares was approved by our stockholders. |
| December 18, 2024 | Mailing of the Information Statement pursuant to Securities and Exchange Act Section 14(f) and Rule 14f-1. |
| December 23, 2024 | A resale registration statement on Form S-3 was filed with the Securities and Exchange Commission to register the shares of Common Stock underlying the convertible notes and the Warrant shares. |
| December 26, 2024 | Receipt of $1.5 million of gross proceeds. |
| December 31, 2024 | Record Date for determining stockholders entitled to notice of the corporate action. |
| January 8, 2025 | Payment of the $4 million balance of gross proceeds and effective date of changes in members of the Board. |
| January 14, 2025 | Filing of a Current Report on Form 8-K stating January 8, 2025 as the effective date of the changes in members of the Board. |
| January 17, 2025 | Date on or about which the Information Statement is first being mailed to stockholders. |
Keywords
private placement, securities issuance, written consent, majority stockholder, Nasdaq Listing Rule 5635, convertible notes, warrants, common stock, dilution, CISO Global
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.